Protagenic Therapeutics, Inc.\new Increase (Decrease) in Other Receivables
Protagenic Therapeutics, Inc.\new (PTIX) reported Increase (Decrease) in Other Receivables of -$6.23 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2018-04-02
- Protagenic Therapeutics, Inc.\new increase (decrease) in other receivables for the quarter ending 2016-12-31 was $198.00, a 92.37% decline year-over-year.
- Protagenic Therapeutics, Inc.\new increase (decrease) in other receivables for the quarter ending 2016-09-30 was $0.00.
- Protagenic Therapeutics, Inc.\new increase (decrease) in other receivables for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Protagenic Therapeutics, Inc.\new increase (decrease) in other receivables for the quarter ending 2016-03-31 was -$6.43K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in other receivables for fiscal 2016 was -$6.23K, a 313.65% decline from fiscal 2015.
- Protagenic Therapeutics, Inc.\new increase (decrease) in other receivables for fiscal 2015 was $2.92K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2016-12-31 | $198.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $198.00 derived: sum of 2 quarters · filed 2018-04-02 | $198.00 derived: sum of 3 quarters · filed 2018-04-02 | -$6.23K 10-K · filed 2018-04-02 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | -$6.43K 10-Q · filed 2017-11-13 | -$3.83K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$6.43K 10-Q · filed 2017-08-08 | -$3.83K derived: sum of 3 quarters · filed 2017-08-08 | -$3.89K derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$6.43K 10-Q · filed 2017-05-15 | -$3.83K derived: sum of 2 quarters · filed 2017-05-15 | -$3.89K derived: sum of 3 quarters · filed 2017-05-15 | $477.00 derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $2.60K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-05-08 | $2.54K derived: sum of 2 quarters · filed 2017-05-08 | $6.91K derived: sum of 3 quarters · filed 2017-05-08 | $2.92K 10-K/A · filed 2017-05-08 |
| 2015-09-30 | -$56.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-17 | $4.31K derived: sum of 2 quarters · filed 2016-11-17 | $321.00 10-Q · filed 2016-11-17 | |
| 2015-06-30 | $4.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $377.00 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | -$3.99K 10-Q · filed 2016-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |